Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
[Cyclophosphamide pulse therapy effective for childhood-onset refractory multiple sclerosis: a case report].
Anti-integrin therapy for multiple sclerosis.
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial.
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis.
Multiple sclerosis treatment: current best practice.
MiR-126: a novel route for natalizumab action?
Drug record: Amiloride
Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells.
Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders.
[Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa].
Design and screening of a glial cell-specific, cell penetrating Peptide for therapeutic applications in multiple sclerosis.
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron.
TAPP1 inhibits the differentiation of oligodendrocyte precursor cells via suppressing the Mek/Erk pathway.
QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.
Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis.
Vitamin D: a natural inhibitor of multiple sclerosis.
Drugs to be Discontinued
A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city.
Trial watch: Chemotherapy with immunogenic cell death inducers.
Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis.
MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?
Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment for use in the EU

Pages